dc.creatorGlotz, Denis
dc.creatorChapman, Jeremy R.
dc.creatorDharnidharka, Vikas R.
dc.creatorHanto, Douglas W.
dc.creatorCastro, Maria C. R.
dc.creatorHirsch, Hans H.
dc.creatorLeblond, Veronique
dc.creatorMehta, Aneesh K.
dc.creatorMoulin, Bruno
dc.creatorPagliuca, Antonio
dc.creatorPascual, Julio
dc.creatorRickinson, Alan B.
dc.creatorRusso, Francesco P.
dc.creatorTrappe, Ralf U.
dc.creatorWebster, Angela C.
dc.creatorZuckermann, Andreas O.
dc.creatorGross, Thomas G.
dc.date.accessioned2013-11-01T11:20:25Z
dc.date.accessioned2018-07-04T16:09:58Z
dc.date.available2013-11-01T11:20:25Z
dc.date.available2018-07-04T16:09:58Z
dc.date.created2013-11-01T11:20:25Z
dc.date.issued2013-08-02
dc.identifierTRANSPLANTATION, PHILADELPHIA, v. 94, n. 8, supl. 1, Part 6, pp. 784-793, OCT 27, 2012
dc.identifier0041-1337
dc.identifierhttp://www.producao.usp.br/handle/BDPI/37386
dc.identifier10.1097/TP.0b013e318269e64f
dc.identifierhttp://dx.doi.org/10.1097/TP.0b013e318269e64f
dc.identifier.urihttp://repositorioslatinoamericanos.uchile.cl/handle/2250/1632288
dc.description.abstractPosttransplant lymphoproliferative disorders (PTLDs) are associated with significant morbidity and mortality among solid-organ transplant patients, but approaches to diagnosis and management vary considerably. An international multidisciplinary panel evaluated current understanding of risk factors and classification systems and developed recommendations to aid in PTLD prevention. We considered evidence on PTLD risk factors including Epstein- Barr virus serostatus and immunosuppression and identified knowledge gaps for future research. Recommendations address prophylactic and preemptive strategies to minimize PTLD development, including modulation of immunosuppression and antiviral drug regimens. Finally, new classification criteria were outlined that may help facilitate standardized reporting and improve our understanding of PTLD.
dc.languageeng
dc.publisherLIPPINCOTT WILLIAMS & WILKINS
dc.publisherPHILADELPHIA
dc.relationTRANSPLANTATION
dc.rightsCopyright LIPPINCOTT WILLIAMS & WILKINS
dc.rightsclosedAccess
dc.subjectEPSTEIN-BARR VIRUS INFECTION
dc.subjectIMMUNOSUPPRESSION
dc.subjectLYMPHOPROLIFERATIVE DISORDER
dc.subjectTRANSPLANTATION
dc.titleThe Seville Expert Workshop for Progress in Posttransplant Lymphoproliferative Disorders
dc.typeArtículos de revistas


Este ítem pertenece a la siguiente institución